HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Geyer Selected Research

Neoplasms (Cancer)

11/2023Intratumoral heterogeneity after targeted therapy in murine cancer models with differing degrees of malignancy.
5/2000Predicting cancer development in oral leukoplakia: ten years of translational research.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Geyer Research Topics

Disease

3Breast Neoplasms (Breast Cancer)
11/2023 - 09/2008
2Neoplasms (Cancer)
11/2023 - 05/2000
1Necrosis
11/2023
1Hemorrhage
11/2023
1Encephalitis (Encephalitis, Rasmussen)
01/2012
1Autonomic Nervous System Diseases (Dysautonomia)
01/2012
1Disease Progression
09/2008
1Heart Failure
11/2000
1Systolic Heart Failure
11/2000

Drug/Important Bio-Agent (IBA)

1Sorafenib (BAY 43-9006)FDA Link
11/2023
1Immune Checkpoint InhibitorsIBA
11/2023
1Tyrosine Kinase InhibitorsIBA
11/2023
1Liposomes (Liposome)IBA
11/2023
1Clodronic Acid (Clodronate)IBA
11/2023
1Angiopoietin-1IBA
11/2023
1ErbB Receptors (EGF Receptor)IBA
01/2023
1Hormones (Hormone)IBA
01/2023
1Glutamate Receptors (Glutamate Receptor)IBA
01/2012
1N-Methylaspartate (NMDA)IBA
01/2012
1AutoantibodiesIBA
01/2012
1Lapatinib (GW572016)FDA Link
09/2008
1Capecitabine (Xeloda)FDA Link
09/2008
1Oxygen (Dioxygen)IBA
11/2000
1RetinoidsIBA
05/2000
1Proteins (Proteins, Gene)FDA Link
05/2000
1retinoic acid receptor betaIBA
05/2000
1Biomarkers (Surrogate Marker)IBA
05/2000

Therapy/Procedure

1Therapeutics
11/2023
1Critical Care (Surgical Intensive Care)
01/2012
1Aftercare (After-Treatment)
05/2000